InnoCare Pharma Limited (HKG:9969)

InnoCare Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 20, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	28,014	12,220	13,112	23,452	21,094	17,378
Market Cap Growth	105.11%	-6.80%	-44.09%	11.18%	21.38%	-
Enterprise Value	22,176	6,114	4,689	14,292	15,136	13,835
Last Close Price	14.65	6.12	6.89	13.64	15.30	13.48
PS Ratio	17.96	11.38	16.11	33.17	16.48	10727.94
PB Ratio	3.84	1.70	1.66	2.71	3.04	4.63
P/TBV Ratio	4.00	1.78	1.73	2.75	3.09	4.78
P/OCF Ratio	-	-	-	-	102.87	-
EV/Sales Ratio	14.22	5.69	5.76	20.22	11.82	8540.54
Debt / Equity Ratio	0.25	0.23	0.23	0.20	0.23	0.37
Asset Turnover	0.15	0.10	0.07	0.07	0.18	0
Inventory Turnover	1.51	1.29	1.39	3.81	11.13	-
Quick Ratio	6.14	7.01	4.13	4.43	19.29	38.75
Current Ratio	6.54	7.45	4.21	4.48	19.49	39.18
Return on Equity (ROE)	-3.55%	-6.50%	-8.71%	-13.44%	-1.51%	-368.36%
Return on Assets (ROA)	-2.10%	-3.52%	-4.15%	-5.48%	-1.91%	-9.77%
Return on Capital (ROIC)	-2.39%	-3.97%	-4.66%	-6.02%	-2.02%	-10.37%
Return on Capital Employed (ROCE)	-3.80%	-6.50%	-8.60%	-9.40%	-2.60%	-12.60%
Earnings Yield	-0.90%	-3.84%	-5.30%	-4.27%	-0.38%	-2.67%
FCF Yield	-0.63%	-3.86%	-7.73%	-3.82%	-0.02%	-2.89%
Buyback Yield / Dilution	5.87%	0.67%	-15.31%	-8.29%	-41.21%	-321.19%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.